Cargando…
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
[Image: see text] Vaccine scaffolds and carrier proteins increase the immunogenicity of subunit vaccines. Here, we developed, characterized, and demonstrated the efficacy of a novel microparticle vaccine scaffold comprised of bacterial peptidoglycan (PGN), isolated as an entire sacculi. The PGN micr...
Autores principales: | Weidenbacher, Payton A.-B., Rodriguez-Rivera, Frances P., Sanyal, Mrinmoy, Visser, Joshua A., Do, Jonathan, Bertozzi, Carolyn R., Kim, Peter S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127789/ https://www.ncbi.nlm.nih.gov/pubmed/35412807 http://dx.doi.org/10.1021/acschembio.2c00140 |
Ejemplares similares
-
Simplified Purification
of Glycoprotein-Modified Ferritin
Nanoparticles for Vaccine Development
por: Weidenbacher, Payton, et al.
Publicado: (2022) -
In situ visualization of Braun’s lipoprotein on E. coli sacculi
por: Sheng, Qi, et al.
Publicado: (2023) -
Discovery of chlamydial peptidoglycan reveals bacteria with murein sacculi but without FtsZ
por: Pilhofer, Martin, et al.
Publicado: (2013) -
Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concern
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2023) -
Designing epitope-focused vaccines via antigen reorientation
por: Xu, Duo, et al.
Publicado: (2022)